Skip to content

Warby Parker stock

WRBYNYSE

Warby Parker Inc., Consumer CyclicalISIN US93403J1060

$30.15▲ $0.25 (+0.8%)Closing price of 11 Nov 2026

50Score 50 out of 100, Neutral

Turn on early warning

Price and trend

87 / 100

Price history

+73% in one year

The chart shows daily closes over 5 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 20% above it.

Trend change

Since November 2026 the 50-day line has been above the 200-day line; the trend has turned up.

Momentum

Normal: the price is neither overheated nor sold off (RSI 64).

Distance to the high

The price is at its 52-week high. Largest decline in 5 years: 84% (November 2021 to March 2023).

Chart figures for advanced users
SMA 50$25.23
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$25.12
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)64
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$16.49
The lowest closing price of the last twelve months.
Resistance$30.34
The highest closing price of the last twelve months.
Market cap
$3.76B
Div. yield
no dividend
509.1
on reported earnings of the last twelve months
50.8
on earnings for the next twelve months ($0.59 per share)
Fair value
$11.61

Snapshot

Computed from the data by fixed rules, no AI

  • Warby Parker Inc. belongs to the Specialty Retail industry (United States) and, with a market value of $3.76B, is number 47 of 86 companies in its industry on MEQIRI.
  • For fiscal 2026, analysts expect on average revenue of $969.2M (up 11.2%) and adjusted earnings per share of $0.43 (up 29.5%).
  • MEQIRI Score 50 out of 100 (Neutral): rank 464 of 602 in Consumer Cyclical, median 61.
Show more
  • Our model puts fair value at $11.61, with the price 160% above it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Earnings turn into cashFree cash flow 285% of earnings over the last 12 months.
  • Analysts expect strong earnings growthUp 39.3% a year through 2028 (estimates from 6 analysts).Growth 70
  • Growing faster than its industryRevenue up 17.2% a year since 2020, Specialty Retail median 11%.Growth 70

Weaknesses

  • Above fair valuePrice 160% above the fair value of $11.61.Valuation 15
  • Volatile share priceVolatility 82% a year over the last 12 months.Stability 69
  • DilutionShare count up 10% since 2020.Capital allocation 29
50/ 100
MEQIRI Score
Neutral

Its standout strengths are technical analysis and momentum, while fundamentals and valuation hold the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

Score since yesterday from 51 to 50.

Fundamental quality fluctuates.

Profit consistency14% of years
Cash conversion (free cash flow to earnings, 12 months)not measured
ROIC (12 months)0.3%
Positive free cash flow57% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk high

How well MEQIRI warns

One of the 30% with the highest crash risk among smaller stocks.

From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • weak fundamentals
  • high price swings

What lowers it

  • price near its 52-week high

Valuation

Valuation signal

Significantly overvalued
Price
$30.15
Fair value
$11.61
Gap to fair value
+160%

In our model the price counts as cheap below $7.74 and expensive above $23.22 (uncertainty very high, based on the price swings of the past year).

The two parts of the fair value come to $21.86 (cash-flow model) and $1.36 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $9.67, at 7.8% it would be $14.53.

Valuation metrics

17.13
57.5
Fair value (model)
$11.61
Earnings part $1.36 (earnings per share $0.06 × 23)

Half from the cash-flow model, half from earnings times the industry P/E (23).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

7 years

In the twelve months to 30 Sep 2026, revenue rose 9.9% on the twelve months before. Revenue has grown strongly since 2019, at around 15% per year.

Margins

7 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 54%, operating −1%, net 0%.

Debt & balance sheet

latest quarter
0.66
> 100x
2.26
Cash & equivalents
$287.91M

The balance sheet is solid, with moderate debt and comfortable interest coverage.

Earnings

Next earnings
25 Feb 2027in 105 days
Last reported
5 Nov 2026EPS reported $0.04 (expected $0.09)below expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 202610 analysts
Earnings per share
$0.43−0.1%
Revenue
$969.2M−0.2%
Fiscal 202710 analysts
Earnings per share
$0.62+0.5%
Revenue
$1.13B−0.3%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook confirmed

Share price after the results: −9.6%

2026 revenue and adjusted EBITDA guidance reaffirmed.

Supporting passage from the call, verbatim
“We are reaffirming our full year revenue and adjusted EBITDA guidance, which now includes the tariff refund benefit and the additional investments we're making ahead of launch.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 6 Aug 2026 (fiscal Q2 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases in the last 6 months. 6 insiders sold, $23.48M in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • Raider Jeffrey JacobSale

    1 Oct 2026, Board

    Shares
    15,000
    Price
    $27.70
    Value
    $415,500
  • Blumenthal Neil HarrisSale

    1 Oct 2026, Co-Chief Executive Officer

    Shares
    100,000
    Price
    $27.69
    Value
    $2.77M
  • Blumenthal Neil HarrisSale

    6 Jul 2026, Co-Chief Executive Officer

    Shares
    9,200
    Price
    $29.99
    Value
    $275,908
Show 10 more
  • Gilboa David AbrahamSale

    6 Jul 2026, Co-Chief Executive Officer

    Shares
    54,347
    Price
    $29.84
    Value
    $1.62M
  • Blumenthal Neil HarrisSale

    1 Jul 2026, Co-Chief Executive Officer

    Shares
    217,667
    Price
    $29.61
    Value
    $6.45M
  • Gilboa David AbrahamSale

    1 Jul 2026, Co-Chief Executive Officer

    Shares
    242,221
    Price
    $29.69
    Value
    $7.19M
  • Raider Jeffrey JacobSale

    1 Jul 2026, Board

    Shares
    22,500
    Price
    $29.72
    Value
    $668,700
  • Blumenthal Neil HarrisSale

    29 Jun 2026, Co-Chief Executive Officer

    Shares
    36,300
    Price
    $30.04
    Value
    $1.09M
  • Briggs TeresaSale

    16 Jun 2026, Board

    Shares
    5,000
    Price
    $25.94
    Value
    $129,683
  • Moon Youngme ESale

    12 Jun 2026, Board

    Shares
    10,000
    Price
    $26.53
    Value
    $265,300
  • Blumenthal Neil HarrisSale

    19 May 2026, Co-Chief Executive Officer

    Shares
    63,040
    Price
    $30.03
    Value
    $1.89M
  • Singer Bradley ESale

    14 May 2026, Board

    Shares
    4,833
    Price
    $29.01
    Value
    $140,205
  • Singer Bradley ESale

    13 May 2026, Board

    Shares
    20,167
    Price
    $28.51
    Value
    $574,961

Partial trades from one filing are shown in one row, with the average price.

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Warby Parker

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

602 rated companies in Consumer Cyclical

Rank 464 of 602
464/ 602
This company
50
Sector median
61

Categories against the sector median

ProfitabilityMedian of 602 companies28 (median 53)25 below the median
GrowthMedian of 602 companies70 (median 60)10 above the median
FundamentalsMedian of 602 companies22 (median 73)51 below the median
ValuationMedian of 580 companies with a value15 (median 72)57 below the median
StabilityMedian of 602 companies69 (median 62)7 above the median
Capital allocationMedian of 602 companies29 (median 58)29 below the median
Technical analysisMedian of 602 companies87 (median 63)24 above the median
MomentumMedian of 602 companies86 (median 62)24 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Specialty Retail

The next larger and next smaller companies by market value

All 86 Specialty Retail stocks

ETFs that hold Warby Parker

Held by 11 ETFs on Xetra. Shown per index: the ETF with the largest weight.

Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 11 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral since 11 Nov 2026, previously Weak
  • Valuation signal Overvalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy